John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
Amazon
AMZN
|
+$243M |
| 3 |
Applied Materials
AMAT
|
+$242M |
| 4 |
Airbnb
ABNB
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$262M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$259M |
| 3 |
Wells Fargo
WFC
|
+$238M |
| 4 |
Broadcom
AVGO
|
+$233M |
| 5 |
Applovin
APP
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.95% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DADA
2451
DELISTED
Dada Nexus
DADA
| $522K | ﹤0.01% |
431,366
-273,170
| -39% | -$436K |
|
2452
Photronics
PLAB
$1.73B
| $522K | ﹤0.01% |
22,146
-14,225
| -39% | -$348K |
|
2453
AtaiBeckley Inc
ATAI
$2.76B
| $520K | ﹤0.01% |
390,877
-16,306
| -4% | -$21.7K |
|
2454
Bit Digital
BTBT
$570M
| $519K | ﹤0.01% |
177,151
| – | – |
|
2455
Acumen Pharmaceuticals
ABOS
$224M
| $518K | ﹤0.01% |
301,268
-8,239
| -3% | -$19.8K |
|
|
RVNC
2456
DELISTED
Revance Therapeutics, Inc.
RVNC
| $517K | ﹤0.01% |
170,136
+13,539
| +9% | +$59K |
|
2457
Rocket Pharmaceuticals
RCKT
$415M
| $517K | ﹤0.01% |
41,142
+19,326
| +89% | +$291K |
|
2458
Sundial Growers
SNDL
$341M
| $515K | ﹤0.01% |
287,816
-123,661
| -30% | -$242K |
|
2459
VanEck Agribusiness ETF
MOO
$1.02B
| $514K | ﹤0.01% |
7,970
-5,500
| -41% | -$390K |
|
2460
Cullinan Oncology
CGEM
$1.48B
| $514K | ﹤0.01% |
42,205
+19,261
| +84% | +$277K |
|
2461
Bowman Consulting
BWMN
$737M
| $513K | ﹤0.01% |
20,552
+7,754
| +61% | +$189K |
|
2462
Neumora Therapeutics
NMRA
$282M
| $512K | ﹤0.01% |
48,290
+686
| +1% | +$8.22K |
|
2463
Utz Brands
UTZ
$1.26B
| $512K | ﹤0.01% |
+32,684
| New | +$553K |
|
2464
IHS Holding
IHS
$2.82B
| $511K | ﹤0.01% |
175,127
+74,207
| +74% | +$225K |
|
2465
NextNav
NN
$2.65B
| $511K | ﹤0.01% |
+32,843
| New | +$438K |
|
2466
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$261M
| $511K | ﹤0.01% |
8,600
-8,900
| -51% | -$540K |
|
2467
Nkarta
NKTX
$194M
| $507K | ﹤0.01% |
203,763
-123,221
| -38% | -$380K |
|
2468
Blue Ridge Bankshares
BRBS
$352M
| $506K | ﹤0.01% |
+157,108
| New | +$495K |
|
2469
Investar Holding Corp
ISTR
$417M
| $506K | ﹤0.01% |
23,031
-4,194
| -15% | -$91.9K |
|
2470
Caledonia Mining Corp
CMCL
$489M
| $503K | ﹤0.01% |
53,497
-8,012
| -13% | -$102K |
|
2471
Standard BioTools
LAB
$255M
| $502K | ﹤0.01% |
286,941
-27,300
| -9% | -$50.9K |
|
2472
GXO Logistics
GXO
$5.44B
| $500K | ﹤0.01% |
11,500
-7,768
| -40% | -$428K |
|
2473
Immatics
IMTX
$1.26B
| $500K | ﹤0.01% |
70,324
-36,345
| -34% | -$312K |
|
2474
HSBC
HSBC
$358B
| $500K | ﹤0.01% |
10,100
-358
| -3% | -$16.6K |
|
2475
Health Catalyst
HCAT
$119M
| $496K | ﹤0.01% |
+70,208
| New | +$559K |
|
Similar funds
John Overdeck's Q4 2024 Portfolio in Review
As of Q4 2024, John Overdeck held 3,590 positions worth $45.9B, up 0.48% from $45.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $1.69B in Q4 2024, closing 427 positions and reducing 1,388 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Intel worth $237M.
- John Overdeck's largest Q4 2024 buy was Intel: 11,843,258 shares worth $237M.
- John Overdeck added most to Amazon in Q4 2024, an estimated $243M increase.
- John Overdeck's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $262M.
- John Overdeck fully exited iShares MSCI Emerging Markets ETF in Q4 2024, selling an estimated $184M.
- John Overdeck's ten largest holdings make up 7.2% of its $45.9B portfolio in Q4 2024.
- John Overdeck opened 477 new positions and closed 427 in Q4 2024.
- John Overdeck's portfolio value rose 0.48% quarter-over-quarter to $45.9B.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.